SciSparc Shareholders Approve AutoMax Merger for EV Market Entry
SciSparc Ltd. (Nasdaq: SPRC), a clinical-stage pharmaceutical company, announced that shareholders of both SciSparc and AutoMax Motors Ltd. have approved their proposed merger. The strategic reverse merger will result in SciSparc acquiring 100% of AutoMax’s share capital, with SciSparc shareholders retaining 50.01% ownership of the combined company….